Adaptive Biotechnologies Corporation
ADPT
NASDAQ·Healthcare·Biotechnology·Mkt cap $3.9B
$24.28
▼ -1.18%
P/E
-59.00
Mkt Cap
$3.9B
52-Wk Range
$12.00–$26.87
52-Week Range
$12.00 - $26.87
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 93.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary immune sequencing technology
- Strategic technology partnerships
- Comprehensive disease diagnostic platform
- Advanced machine learning integration
Bear Case
1 risk
- High volatility (beta 2.1). Larger-than-normal price swings expected.
Growth
Stable outlook
Expanding precision medicine market
Value
Trading at 0.0x Biotech & Therapeutics peers — a discount despite the growth profile.
Momentum
Hot
+45.4% over 3m
Quality
Excellent
High-growth business (50% revenue growth, 75% gross margin). Pre-profit but investing in growth.
Dividend
None
No dividend
Smart-money signal
Who's buying ADPT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
JUL 28, 2026
Reported EPS of -$0.25 vs -$0.13 consensus (-87.1% surprise). Revenue of $71.6M vs $65.4M expected (+9.3%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-87.1%
Revenue trend · last 8Q
—
+4%
+25%
+36%
+102%
+51%
+35%
+22%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$46.4M
$47.5M
$52.4M
$58.9M
$94.0M
$71.7M
$70.9M
$71.6M
Margins · last 8Q
Gross
71.8%
Operating
-22.0%
Profit
-55.6%
Wall Street consensus
6 analysts · 83% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
83%
Hold
17%
Sell
0%
Median Price Target
$22.00
▼ -9.4% vs $24.28
Latest: Piper Sandler · Aug 4, 2026
1 analyst covering
vs Industry
How ADPT stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related